+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Imaging Agents Market - Global Forecast 2026-2032- Product Image
Imaging Agents Market - Global Forecast 2026-2032- Product Image
Sale

Imaging Agents Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5888774
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Imaging Agents Market is projected to reach USD 11.40 Billion in 2026. It is expected to continue growing at a CAGR of 6.73%, reaching USD 16.99 Billion by 2032.

Imaging Agents: Executive Overview

Imaging agents are substances administered to improve the visibility of anatomical structures, physiological processes, or disease-related abnormalities during diagnostic imaging. Their use spans radiography, computed tomography, magnetic resonance imaging, ultrasound, and nuclear medicine. Clinical value depends on diagnostic performance, patient safety, workflow integration, supply reliability, and compliance with evolving regulatory requirements.

Safety, Workflow, and Precision Are Reshaping Imaging Agents

The landscape is shifting toward agents that support more precise diagnosis while reducing adverse reactions, preparation time, and operational complexity. Hospitals and imaging centers are placing greater emphasis on standardized protocols, renal and allergic-risk assessment, dose optimization, product traceability, and dependable distribution. Broader adoption of advanced imaging is also increasing the need for specialized agents compatible with complex modalities and time-sensitive clinical pathways.

Artificial Intelligence Amplifies the Clinical Value of Imaging Agents

Artificial intelligence is influencing imaging-agent use by improving examination selection, protocol customization, image reconstruction, lesion detection, and quantitative interpretation. These capabilities can help clinicians identify patients most likely to benefit from contrast-enhanced studies and tailor acquisition parameters to clinical questions. Effective deployment still requires representative validation data, human oversight, interoperability with imaging systems, cybersecurity controls, and clear accountability for clinical decisions.

Regional Dynamics Reflect Uneven Access and Regulatory Priorities

North America combines advanced imaging infrastructure with strong attention to safety monitoring, utilization management, and workflow efficiency. Latin America is shaped by uneven access to high-end equipment, procurement constraints, and the need for reliable distribution across urban and remote settings. Europe emphasizes harmonized regulation, patient safety, sustainability, and cross-border healthcare practices. The Middle East is investing in specialized healthcare capacity while addressing workforce and supply-chain requirements. Africa presents substantial opportunities to improve diagnostic access, supported by mobile services, public-health programs, and infrastructure development. Asia-Pacific combines rapid healthcare expansion, diverse regulatory environments, large patient populations, and growing demand for efficient, scalable imaging pathways.

Economic and Security Groups Shape Standards and Supply Resilience

ASEAN economies face varied healthcare capacity and regulatory conditions, making adaptable distribution and training important. BRICS members bring diverse manufacturing, research, and healthcare priorities, with emphasis on domestic capability and access. The European Union is guided by coordinated safety, data, environmental, and medical-device frameworks. G7 systems generally prioritize evidence quality, pharmacovigilance, innovation, and resilient procurement. GCC countries are strengthening advanced-care infrastructure and specialist services. NATO members increasingly consider continuity of medical supply and critical-healthcare resilience alongside clinical performance.

Country-Level Priorities Span Innovation, Access, and Resilience

Australia is focused on equitable access across dispersed populations and robust hospital protocols. Brazil is balancing expanding diagnostic capacity with regional disparities and public-sector procurement needs. Canada emphasizes safety, access across large geographies, and coordinated healthcare delivery. China is strengthening domestic innovation, manufacturing capability, and diagnostic infrastructure. France and Germany prioritize rigorous evidence, safety, reimbursement discipline, and integrated care. India is addressing affordability, capacity expansion, and access beyond major urban centers. Italy and Spain are concentrating on efficient public healthcare utilization and regional service consistency. Japan emphasizes quality, aging-population needs, and advanced imaging workflows. Mexico is working to broaden diagnostic access while managing infrastructure and procurement variation. Russia is focused on supply continuity and domestic healthcare capability. South Korea combines technology-intensive care with strong clinical and manufacturing capabilities. The United Kingdom emphasizes evidence-based adoption, safety governance, and health-system efficiency. The United States remains centered on advanced imaging, clinical productivity, regulatory compliance, and monitoring of patient risk.

Actions for Leaders: Build Safer, Smarter, More Resilient Imaging Pathways

Industry leaders should align product development with clearly defined clinical use cases, measurable safety outcomes, and compatibility with modern imaging workflows. They should strengthen real-world evidence programs, maintain robust adverse-event surveillance, and support protocol standardization with practical education for radiology and nursing teams. Supply resilience requires qualified alternative sources, transparent inventory monitoring, and contingency planning. AI initiatives should be validated in representative clinical environments and integrated with governance, cybersecurity, and human review. Regional strategies should also reflect reimbursement conditions, local infrastructure, regulatory requirements, and the capabilities of public and private providers.

Research Methodology: Evidence-Led Assessment of Imaging-Agent Dynamics

This executive summary uses a structured qualitative assessment of imaging-agent applications, clinical workflows, technology developments, regulatory themes, healthcare-system priorities, and regional access conditions. The analysis organizes findings across the required regions, economic and security groups, and countries, emphasizing observable drivers such as diagnostic adoption, safety expectations, infrastructure, procurement, supply continuity, and digital integration. It excludes market estimates, market sizing, market shares, forecasts, and unsupported claims, and treats artificial intelligence as an enabling technology whose value depends on clinical validation and responsible implementation.

Conclusion: Clinical Utility Depends on Trust, Access, and Execution

The imaging-agents landscape is being shaped by the combined demands of diagnostic precision, patient safety, operational efficiency, digital integration, and dependable supply. Differences among regions, country systems, and economic groups require locally appropriate strategies rather than a single global approach. Organizations that connect evidence generation with responsible AI, resilient operations, workforce support, and equitable access will be better positioned to deliver consistent clinical value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Imaging Agents Market, by Agent Type
7.1. Introduction
7.2. Gadolinium Based Agents
7.3. Iodinated Contrast Agents
7.4. Microbubble Agents
7.5. Radiopharmaceuticals
8. Imaging Agents Market, by Modality
8.1. Introduction
8.2. Computed Tomography
8.3. Magnetic Resonance Imaging
8.4. Nuclear Imaging
8.5. Ultrasound Imaging
9. Imaging Agents Market, by Application
9.1. Introduction
9.2. Cardiology
9.3. Gastroenterology
9.4. Musculoskeletal
9.5. Neurology
9.6. Oncology
10. Imaging Agents Market, by End User
10.1. Introduction
10.2. Academic Research Institutes
10.3. Ambulatory Surgical Centers
10.4. Diagnostic Laboratories
10.5. Hospitals And Imaging Centers
11. Imaging Agents Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.3. Online
12. Imaging Agents Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Imaging Agents Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Imaging Agents Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Beijing Beilu Pharmaceutical Co., Ltd.
16.2. Blue Earth Diagnostics
16.3. Bracco S.p.A.
16.4. Cardinal Health, Inc.
16.5. Curium Pharma
16.6. GE HealthCare Technologies Inc.
16.7. Guerbet SA
16.8. Jiangsu Hengrui Pharmaceuticals
16.9. Jubilant Radiopharma
16.10. nanoPET Pharma GmbH
16.11. Navidea Biopharmaceuticals
16.12. Nordion Inc.
16.13. Piramal Group
16.14. SOFIE Biosciences
16.15. Yangtze River Pharmaceutical Group
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Imaging Agents Market, Years Considered for the Study
FIGURE 2. Global Imaging Agents Market, Research Design
FIGURE 3. Global Imaging Agents Market, Research Framework
FIGURE 4. Global Imaging Agents Market, Data Triangulation
FIGURE 5. Global Imaging Agents Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Imaging Agents Market Size, by Agent Type, 2025 vs 2032 (%)
FIGURE 7. Global Imaging Agents Market Size, by Agent Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Imaging Agents Market Size, by Modality, 2025 vs 2032 (%)
FIGURE 9. Global Imaging Agents Market Size, by Modality, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Imaging Agents Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Imaging Agents Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Imaging Agents Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Imaging Agents Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Imaging Agents Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Imaging Agents Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Imaging Agents Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Imaging Agents Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Imaging Agents Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Imaging Agents Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Imaging Agents Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Imaging Agents Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Imaging Agents Market Segmentation & Coverage
TABLE 2. Global Imaging Agents Market Size, 2017-2032 (USD Million)
TABLE 3. Global Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 4. Global Gadolinium Based Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Gadolinium Based Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Gadolinium Based Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Iodinated Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Iodinated Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Iodinated Contrast Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Microbubble Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Microbubble Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Microbubble Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 17. Global Computed Tomography Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Computed Tomography Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Computed Tomography Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Magnetic Resonance Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Magnetic Resonance Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Magnetic Resonance Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Nuclear Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Nuclear Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Nuclear Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Ultrasound Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Ultrasound Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Ultrasound Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 30. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Gastroenterology Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Gastroenterology Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Gastroenterology Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Musculoskeletal Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Musculoskeletal Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Musculoskeletal Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 46. Global Academic Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Academic Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Academic Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Hospitals And Imaging Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Hospitals And Imaging Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Hospitals And Imaging Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 59. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Imaging Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Imaging Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 72. North America Imaging Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. North America Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 74. North America Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 75. North America Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 76. North America Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. North America Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 78. Latin America Imaging Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Latin America Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 80. Latin America Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 81. Latin America Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 82. Latin America Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 83. Latin America Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 84. Europe Imaging Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Europe Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 86. Europe Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 87. Europe Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 88. Europe Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 89. Europe Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 90. Middle East Imaging Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Middle East Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 92. Middle East Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 93. Middle East Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 94. Middle East Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 95. Middle East Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 96. Africa Imaging Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Africa Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 98. Africa Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 99. Africa Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 100. Africa Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 101. Africa Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 102. Global Imaging Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. ASEAN Imaging Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. ASEAN Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 105. ASEAN Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 106. ASEAN Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 107. ASEAN Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. ASEAN Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 109. GCC Imaging Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. GCC Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 111. GCC Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 112. GCC Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. GCC Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. GCC Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 115. European Union Imaging Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. European Union Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 117. European Union Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 118. European Union Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. European Union Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. European Union Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 121. BRICS Imaging Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. BRICS Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 123. BRICS Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 124. BRICS Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. BRICS Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. BRICS Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 127. G7 Imaging Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. G7 Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 129. G7 Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 130. G7 Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 131. G7 Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. G7 Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 133. NATO Imaging Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. NATO Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 135. NATO Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 136. NATO Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 137. NATO Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. NATO Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 139. Global Imaging Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. United States Imaging Agents Market Size, 2017-2032 (USD Million)
TABLE 141. United States Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 142. United States Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 143. United States Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. United States Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. United States Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 146. Canada Imaging Agents Market Size, 2017-2032 (USD Million)
TABLE 147. Canada Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 148. Canada Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 149. Canada Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. Canada Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. Canada Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 152. Mexico Imaging Agents Market Size, 2017-2032 (USD Million)
TABLE 153. Mexico Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 154. Mexico Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 155. Mexico Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. Mexico Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. Mexico Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 158. Brazil Imaging Agents Market Size, 2017-2032 (USD Million)
TABLE 159. Brazil Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 160. Brazil Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 161. Brazil Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. Brazil Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. Brazil Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 164. United Kingdom Imaging Agents Market Size, 2017-2032 (USD Million)
TABLE 165. United Kingdom Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 166. United Kingdom Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 167. United Kingdom Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. United Kingdom Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. United Kingdom Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 170. Germany Imaging Agents Market Size, 2017-2032 (USD Million)
TABLE 171. Germany Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 172. Germany Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 173. Germany Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. Germany Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Germany Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 176. France Imaging Agents Market Size, 2017-2032 (USD Million)
TABLE 177. France Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 178. France Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 179. France Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 180. France Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. France Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 182. Russia Imaging Agents Market Size, 2017-2032 (USD Million)
TABLE 183. Russia Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 184. Russia Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 185. Russia Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. Russia Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. Russia Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 188. Italy Imaging Agents Market Size, 2017-2032 (USD Million)
TABLE 189. Italy Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 190. Italy Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 191. Italy Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. Italy Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. Italy Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 194. Spain Imaging Agents Market Size, 2017-2032 (USD Million)
TABLE 195. Spain Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 196. Spain Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 197. Spain Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. Spain Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. Spain Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 200. China Imaging Agents Market Size, 2017-2032 (USD Million)
TABLE 201. China Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 202. China Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 203. China Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. China Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. China Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 206. India Imaging Agents Market Size, 2017-2032 (USD Million)
TABLE 207. India Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 208. India Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 209. India Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. India Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. India Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 212. Japan Imaging Agents Market Size, 2017-2032 (USD Million)
TABLE 213. Japan Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 214. Japan Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 215. Japan Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 216. Japan Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. Japan Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 218. Australia Imaging Agents Market Size, 2017-2032 (USD Million)
TABLE 219. Australia Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 220. Australia Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 221. Australia Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. Australia Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. Australia Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 224. South Korea Imaging Agents Market Size, 2017-2032 (USD Million)
TABLE 225. South Korea Imaging Agents Market Size, by Agent Type, 2017-2032 (USD Million)
TABLE 226. South Korea Imaging Agents Market Size, by Modality, 2017-2032 (USD Million)
TABLE 227. South Korea Imaging Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. South Korea Imaging Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. South Korea Imaging Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 230. Global Imaging Agents Market Share, by Key Player, 2025
TABLE 231. Global Imaging Agents Market, Key Experts

Companies Mentioned

  • Beijing Beilu Pharmaceutical Co., Ltd.
  • Blue Earth Diagnostics
  • Bracco S.p.A.
  • Cardinal Health, Inc.
  • Curium Pharma
  • GE HealthCare Technologies Inc.
  • Guerbet SA
  • Jiangsu Hengrui Pharmaceuticals
  • Jubilant Radiopharma
  • nanoPET Pharma GmbH
  • Navidea Biopharmaceuticals
  • Nordion Inc.
  • Piramal Group
  • SOFIE Biosciences
  • Yangtze River Pharmaceutical Group

Related Topics

Related Reports

Optical Imaging Agent Market - Global Forecast 2026-2032 - Product Image

Optical Imaging Agent Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Low Density Contrast Media Market - Global Forecast 2026-2032 - Product Image

Low Density Contrast Media Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Biological Imaging Reagents - Global Strategic Business Report - Product Image

Biological Imaging Reagents - Global Strategic Business Report

  • Report
  • 340 Pages
  • Global
From
Diagnostic Radiopharmaceuticals and Contrast Media - Global Strategic Business Report - Product Image

Diagnostic Radiopharmaceuticals and Contrast Media - Global Strategic Business Report

  • Report
  • 278 Pages
  • Global
From
Contrast Media Market Report by Type, Modality, Application, Route of Administration, End User, and Region 2026-2034 - Product Image

Contrast Media Market Report by Type, Modality, Application, Route of Administration, End User, and Region 2026-2034

  • Report
  • 135 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.